| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1196/ANNALS.1403.003 |
| P698 | PubMed publication ID | 18077563 |
| P50 | author | Gregory F. Oxenkrug | Q47202727 |
| P2093 | author name string | Gregory F Oxenkrug | |
| P2860 | cites work | Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types | Q24310976 |
| A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice | Q28236928 | ||
| Endogenous neurotoxins from tryptophan | Q31425931 | ||
| Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway | Q33871711 | ||
| National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards | Q33998646 | ||
| Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences | Q34314732 | ||
| Hepatitis C, interferon a and depression: main physiopathologic hypothesis | Q34448376 | ||
| The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase | Q34715866 | ||
| Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities | Q34863910 | ||
| Cytokines in Dementias | Q35560641 | ||
| Inhibition of experimental asthma by indoleamine 2,3-dioxygenase | Q35835456 | ||
| Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis | Q35848218 | ||
| Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implications. | Q36265321 | ||
| The HPA and immune axes in stress: the involvement of the serotonergic system | Q36387415 | ||
| Excitotoxicity of quinolinic acid: modulation by endogenous antagonists | Q40314127 | ||
| Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis | Q42448676 | ||
| Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism | Q43690832 | ||
| Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection | Q43718624 | ||
| Effects of tryptophan loading on verbal, spatial and affective working memory functions in healthy adults | Q43841242 | ||
| Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway. | Q44443003 | ||
| Periventricular cerebral white matter lesions predict rate of cognitive decline | Q44905904 | ||
| Tryptophan loading induces oxidative stress | Q45204042 | ||
| Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease | Q45301717 | ||
| Association of interferon-gamma +874(T/A) single nucleotide polymorphism with the rate of tryptophan catabolism in healthy individuals | Q46457375 | ||
| Prolactin (PRL) up-regulates indoleamine 2,3-dioxygenase (IDO) expression in CD14+ cells | Q46880783 | ||
| Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. | Q46886262 | ||
| Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality | Q46972515 | ||
| Ibudilast, a phosphodiesterase inhibitor, protects against white matter damage under chronic cerebral hypoperfusion in the rat. | Q47398572 | ||
| White matter hyperintensities and gray matter lesions in physically healthy depressed subjects | Q48092203 | ||
| Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity | Q48357956 | ||
| Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice | Q48477920 | ||
| Effects of sex hormones on the metabolism of tryptophan to niacin and to serotonin in male rats | Q48666226 | ||
| Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques | Q48736224 | ||
| Epidemiology: identifying vascular cognitive impairment | Q48762922 | ||
| Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study | Q48788280 | ||
| Neuropsychological correlates of MRI measures in the continuum of cognitive decline at old age. | Q48864565 | ||
| Vascular cognitive impairment. | Q52006834 | ||
| Aging and cortisol resistance to suppression by dexamethasone: a positive correlation | Q57318005 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | major depressive disorder | Q42844 |
| cognitive dysfunction | Q57859955 | ||
| P304 | page(s) | 35-49 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging | |
| P478 | volume | 1122 |
| Q37725843 | A psychoneuroimmunological review on cytokines involved in antidepressant treatment response |
| Q48261958 | Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension. |
| Q55381445 | An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase—Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases. |
| Q92376687 | Antidepressant-Like Effect and Mechanism of Action of Honokiol on the Mouse Lipopolysaccharide (LPS) Depression Model |
| Q37055629 | Attenuation of high sucrose diet-induced insulin resistance in ABC transporter deficient white mutant of Drosophila melanogaster |
| Q35855016 | Attenuation of high sucrose diet-induced insulin resistance in tryptophan 2,3-dioxygenase deficient Drosophila melanogaster vermilion mutants. |
| Q90084710 | Benserazide, an Inhibitor of Peripheral Kynurenine Metabolism, Attenuates Olanzapine-Induced Weight Gain, Insulin Resistance, and Dyslipidemia in C57Bl/6j Mice |
| Q35838662 | Berberine Prolongs Life Span and Stimulates Locomotor Activity of Drosophila melanogaster |
| Q38129457 | Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome. |
| Q34243822 | Cognitive performance in older elderly men with late-life depression and cardiovascular comorbidities: symptomatological correlation. |
| Q35755435 | Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways |
| Q37717023 | Crosstalk between Tryptophan Metabolism and Cardiovascular Disease, Mechanisms, and Therapeutic Implications |
| Q37650028 | Depressive disorder and gastrointestinal dysfunction after myocardial infarct are associated with abnormal tryptophan-5-hydroxytryptamine metabolism in rats |
| Q87793088 | Effect of kynurenic acid on development and aging in wild type and vermilion mutants of Drosophila melanogaster |
| Q46956639 | Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression |
| Q36608481 | Examining the relationship between diet-induced acidosis and cancer |
| Q35678168 | Executive functions in elderly men. |
| Q35694510 | Extension of life span of Drosophila melanogaster by the inhibitors of tryptophan-kynurenine metabolism |
| Q38861231 | HORSE SPECIES SYMPOSIUM: Canine intestinal microbiology and metagenomics: From phylogeny to function |
| Q34043256 | Identification of a variable number of tandem repeats polymorphism and characterization of LEF-1 response elements in the promoter of the IDO1 gene |
| Q48432437 | Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke |
| Q37188890 | Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways |
| Q34812879 | Interferon-gamma (+874) T/A genotypes and risk of IFN-alpha-induced depression |
| Q34520722 | Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders |
| Q90732124 | Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis |
| Q37802769 | Kynurenine metabolism in health and disease |
| Q39315645 | Kynurenines and other novel therapeutic strategies in the treatment of dementia |
| Q85983648 | Kynurenines and vitamin B6: link between diabetes and depression |
| Q40218658 | Maternal Inflammation Results in Altered Tryptophan Metabolism in Rabbit Placenta and Fetal Brain. |
| Q36409142 | Minocycline effect on life and health span of Drosophila melanogaster |
| Q36409066 | N-acetylserotonin and aging-associated cognitive impairment and depression. |
| Q35720151 | Neopterin, a Marker of Interferon-Gamma-Inducible Inflammation, Correlates with Pyridoxal-5'-Phosphate, Waist Circumference, HDL-Cholesterol, Insulin Resistance and Mortality Risk in Adult Boston Community Dwellers of Puerto Rican Origin |
| Q37460122 | Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease |
| Q41139088 | On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo |
| Q37831342 | Pathobiological targets of depression. |
| Q42566452 | Pathogenic antibodies are active participants in spinal cord injury |
| Q37799815 | Post-translational modifications of mitochondrial outer membrane proteins |
| Q34168670 | Primary murine microglia are resistant to nitric oxide inhibition of indoleamine 2,3-dioxygenase |
| Q39593867 | Saliva and blood interferon gamma levels and IFNG genotypes in acute graft-versus-host disease. |
| Q62590802 | Searching for the Role of the IFNγ rs2430561 Polymorphism in Inducible Inflammation: Contribution to Metabolic Syndrome in 45 to 60-Year-Old Women |
| Q27012779 | Serotonin-kynurenine hypothesis of depression: historical overview and recent developments |
| Q94464760 | Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges |
| Q46775759 | Targeting Oxidative Stress, Cytokines and Serotonin Interactions Via Indoleamine 2, 3 Dioxygenase by Coenzyme Q10: Role in Suppressing Depressive Like Behavior in Rats |
| Q36259108 | Targeting inflammation to influence mood following spinal cord injury: a randomized clinical trial |
| Q47865416 | The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity |
| Q52662001 | The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression. |
| Q36763697 | The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness*. |
| Q38245307 | The common inflammatory etiology of depression and cognitive impairment: a therapeutic target |
| Q47847270 | The effects of vagus nerve stimulation on tryptophan metabolites in children with intractable epilepsy. |
| Q34455273 | The extended life span of Drosophila melanogaster eye-color (white and vermilion) mutants with impaired formation of kynurenine |
| Q37899782 | The kynurenine system and immunoregulation |
| Q33568518 | The learned safety paradigm as a mouse model for neuropsychiatric research |
| Q38171958 | The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors. |
| Q47201558 | The role of tryptophan metabolism in postpartum depression |
| Q42495952 | Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice |
| Q26765775 | Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in Humans |
| Q34495694 | Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later |
| Q37182605 | Tryptophan-kynurenine metabolism and insulin resistance in hepatitis C patients. |
Search more.